BUENA, N.J.--(BUSINESS WIRE)--IGI Laboratories, Inc. (NYSE AMEX:IG), a premier provider of topical formulation development, analytical, manufacturing and packaging services, today announced that it received an extension from NYSE Amex to regain compliance with its listing standards until May 31, 2009.
